08 October 2015

BRIEFINGS

CTA Intelligence Chicago Briefing: Debunking the myth of illiquidity in security futures

Join CTA Intelligence for its third Chicago briefing, taking place on Thursday 8 October.



Date: 08 October 2015


Venue: The Ritz-Carlton Chicago ( Four Seasons Hotel)


Register Now
Add to Calendar 10/08/2015 15:30 America/New_York CTA Intelligence Chicago Briefing: Debunking the myth of illiquidity in security futures Join CTA Intelligence for its third Chicago briefing, taking place on Thursday 8 October. The Ritz-Carlton Chicago ( Four Seasons Hotel) false MM/DD/YYYY
  • Save for later

Join CTA Intelligence for our next Chicago Briefing, a free to attend event, held exclusively for CTA Intelligence & HFM members. Featuring a panel-led discussion and informal networking, the Briefing is an excellent opportunity to update your knowledge, whilst meeting with your peers and connecting with new business contacts.

Debunking the myth of illiquidity in security futures

Sponsored by:
Screen Shot 2015-09-23 at 14.32.24

-Exploring how the liquidity of single stock futures can expand your trading universe
-How OneChicago exchange is bridging the gap between US broker dealers and FCMs
-Why CTAs can get the lowest rates for carrying positions in the equity markets

Agenda:

15:30 Registration & networking
16:10 Introduction by CTA Intelligence
16:15 Panel discussion – Debunking the myth of illiquidity in security futures
17:00 Questions
17:15 Close

Speakers:

– Annette Waite, director, trading and execution, Sunrise Capital Partners
– Mark Eaton, director, global execution services, Societe Generale
– David Downey, CEO, OneChicago

How to attend the Briefing:

All HFM and CTA Intelligence members are welcome to attend the Briefing. To book your place, follow the link below:

REGISTER FOR THIS BREAKFAST >>

If you are not currently a member, you can attend the briefing by taking out a free trial to CTA Intelligence. Please contact Antonio Rua a.rua@pageantmedia.com or +44 (0) 20 7832 6581 to arrange your trial.